STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

APVO APTEVO THERAPEUTICS INCORPORATED StockScouter® Report

5

StockScouter® Score

APTEVO THERAPEUTICS INCORPORATED, a micro cap value company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive

 

Concerns

  • The 50-day moving average for APVO is significantly below its 200-day moving average. Negative
  • The multi-period measure of relative price change and consistency is below average. Negative/Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, value stocks will be neutral, and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 80% done.
Progress: 80% done.
Low
High

Core Model Grades

A
N/A
B
D

Previous Ratings

3